Aug 10–16, 2026 · 10 new studies, 3 reviews · Orthopaedic Oncology archive · All weeks
The new Orthopaedic Oncology research The Reduction sent the week of Aug 10–16, 2026, with the week’s most recent reviews, each with a one-line summary.
Get papers like these by email, free: subscribe to The Reduction, focused on your interests, on the days you pick.
In 20 GCT patients, ICG near-infrared fluorescence imaging detected residual tumor after curettage with 68% accuracy, offering a promising but imperfect adjunct to reduce recurrence.
In a prospective study of multiple myeloma patients, osteolytic lesions with fracture risk and pre-existing orthopedic disease independently predicted bone pain, which significantly worsened quality of life—underscoring the need for interdisciplinary care.
A machine-learning-derived centromere gene signature predicts osteosarcoma prognosis and immune microenvironment status, while B3GALT4 was validated as a tumor suppressor that inhibits osteosarcoma cell proliferation and migration.
Clinical application of urinary NTx in patients with bone metastases from lung cancer.
Urinary NTx/creatinine ratio effectively identifies bone metastases in lung cancer patients, and combining it with serum ALP and calcium substantially improves diagnostic accuracy (AUC 0.882 vs 0.78 alone).
Identification of immunopeptides (pHLA) as candidate therapeutic targets in chondrosarcoma.
Immunopeptidomic profiling of chondrosarcoma identified cancer/testis antigen-derived HLA-presented peptides—including known and novel targets—linked to poor prognosis, offering candidate targets for T-cell–based immunotherapies.
In chondrosarcoma spheroid models, Hippo/YAP-TAZ inhibition with Verteporfin increased radiosensitivity via autophagic disruption, apoptosis, and DNA damage, suggesting a potential strategy to overcome radioresistance.
Metal ion exposure after oncologic megaprosthesis salvage surgery: a systematic review.
A systematic review of 247 oncologic megaprosthesis patients found blood cobalt, chromium, and titanium levels rise over time (some exceeding typical thresholds), though clinical significance for toxicity or ARMD remains unclear.
Detailing long-term functional morbidity after resecting mobile spine chordomas across 35 patients.
In 35 mobile spine chordoma resections, Enneking-appropriate en bloc surgery was not associated with higher rates of long-term motor weakness compared to inappropriate resection, despite similar nerve root sacrifice rates.
In 10 pediatric patients undergoing tibial reconstruction with contralateral vascularized fibular graft after adamantinoma/OFD-like adamantinoma resection, all achieved bone union with good oncologic and functional outcomes, though graft fractures and other complications occurred.
In this UK retrospective study of 140 noninvasive expandable prostheses, total femoral and diaphyseal replacements had substantially higher mechanical failure rates than distal femoral implants, supporting tailored surgical planning and rehab for high-risk implant types.
This review finds PET-CT reliably tracks neoadjuvant treatment response and detects systemic recurrence in soft-tissue sarcomas but has limitations distinguishing benign from malignant uptake and detecting small pulmonary metastases.
Prediction tools for the personalized management of soft-tissue sarcomas of the extremity.
This annotation reviews available prediction tools for extremity soft-tissue sarcoma, offering guidance on evaluating their usefulness for personalized clinical decision-making.
What's New in Pediatric Orthopaedic Tumor Surgery.
This review of pediatric orthopaedic oncology literature from 2014-2020 summarizes key advances in limb salvage, bone cyst management, and sarcoma basic science, while noting persistent gaps in high-level evidence.
← Week of Aug 3–9, 2026Week of Aug 24–30, 2026 →
Home · All weeks · Archive · Subscribe · FAQ
© 2026 The Reduction